RCUS Stock: Arcus Biosciences, Inc. Stock Price, Analysis & Insights
Get live RCUS stock price $22.31, comprehensive Arcus Biosciences, Inc. stock analysis, charts, news, and expert forecast. Real-time RCUS stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Arcus Biosciences, Inc. is a U.S.-based, clinical-stage biopharmaceutical company dedicated to discovering and commercializing innovative cancer therapies. Its pipeline features several promising drug candidates: Etrumadenant, a dual A2a/A2b adenosin...
Company Information
- CEO
- Terry J. Rosen
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 627
Contact Information
- Website
- https://www.arcusbio.com
- Address
- 3928 Point Eden Way
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Arcus Biosciences, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Arcus Biosciences, Inc.
- ⚠Investors should consider how Arcus Biosciences, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
2.25B
P/E Ratio (TTM)
-7.04
Beta
0.84
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare RCUS with peer companies:
- Price
- $28.26
- Market cap
- 1.68B
- Price
- $30.15
- Market cap
- 3.10B
- Price
- $31.38
- Market cap
- 5.36B
- Price
- $20.78
- Market cap
- 3.30B
- Price
- $14.84
- Market cap
- 2.20B
- Price
- $27.98
- Market cap
- 1.84B
- Price
- $7.11
- Market cap
- 7.45B
- Price
- $66.10
- Market cap
- 5.88B
- Price
- $8.40
- Market cap
- 1.84B
- Price
- $15.76
- Market cap
- 1.42B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.